Back to search

Article

Effect of Calcium Dobesilate (CaD) on Diabetic Macular Edema Treated by Intravitreal Ranibizumab

2021-08-31

Abstract excerpt

<h4>Background: </h4> Calcium dobesilate (CaD) had been used in the treatment of diabetic retinopathy (DR) due to its potential in protecting against retinal vascular damage. However, it did not reduce the risk of development of diabetic macular edema (DME). The aim of this study was to investigate the effect of CaD plus intravitreal ranibizumab in the treatment of DME. <h4>Methods: </h4>: This retrospective, obse...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
bfd6fcb4-7608-5f16-ab3e-6e29fd293a1f
DOI
10.21203/rs.3.rs-830956/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 10 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Effect of Calcium Dobesilate (CaD) on Diabetic Macular Edema Treated by Intravitreal RanibizumabDOI 10.21203/rs.3.rs-830956/v1
Select a neighboring publication to make it the new centre.